MR Quality + Diagnostic Performance for CHC Diagnosis - Gadoxetic Acid, Gadoteric Acid and P03277 Comparison

University Hospital, Angers30 enrolled

Overview

Compare diagnostic MRI performance of gadoteric acid, gadoxetic acid and P03277 for suspected CHC nodules less than 3 cm, using LIRADS criteria

Study Type

OBSERVATIONAL

Enrollment

Conditions

Hepatocellular Carcinoma

Interventions

MRI diagnosticDIAGNOSTIC_TEST

no intervention, patient only have MRI

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients who had all three MRI scans as part of the diagnosis of the same suspected CHC lesion(s) * Reference diagnosis obtained for suspected CHC nodules by a diagnostic algorithm taking into account histology, imaging and follow-up Exclusion Criteria: * Delay between first MRI and 3rd MRI greater than 3 months

Outcomes

Primary Outcomes

compare diagnostic MRI performance of gadoteric acid, gadoxetic acid and P03277 for suspected CHC nodules

the evaluation criteria will be the classification of each nodule according to the LiRADS citeria

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.